// App-Quantinova.ai

63 : EpiScan: A synthetic biology platform for targeted immunopeptidomics

Researchers

Presenter

  • Peter Bruno

Principal Investigators

  • Richard Timms

  • Nouran Abdelfattah

  • Yumei Leng

  • Felipe Lelis

  • Duane Wesemann

  • Xu Yu

  • Stephen Elledge

Medical Centers

  • Harvard Medical School, Boston, MA

  • Brigham & Women's Hospital, Boston, MA

  • Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA

  • Department of Genetics, Harvard Medical School and Division of Genetics, Brigham and Women’s Hospital, Boston, MA, USA, and Howard Hughes Medical Institute, Chevy Chase, MD, USA

  • University of Cambridge, Cambridge, UK

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved